Abstract

Percutaneous mitral valve repair (PMVR) using the MitraClip system (Evalve Inc., Menlo Park, California) has emerged as a minimally invasive treatment option for patients at prohibitive risk for surgical treatment of mitral regurgitation (MR). However, a reduction of MR severity may be at the cost

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call